VRCA Logo

Verrica Pharmaceuticals Inc. (VRCA) 

NASDAQ
Market Cap
$299.06M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
34 of 809
Rank in Industry
29 of 445

Largest Insider Buys in Sector

VRCA Stock Price History Chart

VRCA Stock Performance

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Insider Activity of Verrica Pharmaceuticals Inc.

Over the last 12 months, insiders at Verrica Pharmaceuticals Inc. have bought $13.51M and sold $1.14M worth of Verrica Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at Verrica Pharmaceuticals Inc. have bought $8.13M and sold $1.35M worth of stock each year.

Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC (10 percent owner) — $212.55M. Manning Paul B () — $5.02M.

The last purchase of 115,774 shares for transaction amount of $838,204 was made by PERCEPTIVE ADVISORS LLC (10 percent owner) on 2023‑12‑29.

List of Insider Buy and Sell Transactions, Verrica Pharmaceuticals Inc.

2023-12-29PurchasePERCEPTIVE ADVISORS LLC10 percent owner
115,774
0.2752%
$7.24$838,204-10.90%
2023-12-28PurchasePERCEPTIVE ADVISORS LLC10 percent owner
126,116
0.2934%
$7.08$892,901-10.48%
2023-12-27PurchasePERCEPTIVE ADVISORS LLC10 percent owner
79,726
0.1901%
$7.20$574,027-7.51%
2023-12-26PurchasePERCEPTIVE ADVISORS LLC10 percent owner
54,652
0.1301%
$6.49$354,691+2.77%
2023-12-22PurchasePERCEPTIVE ADVISORS LLC10 percent owner
250,000
0.5943%
$6.67$1.67M-1.48%
2023-12-21PurchasePERCEPTIVE ADVISORS LLC10 percent owner
200,000
0.4555%
$6.17$1.23M+3.57%
2023-12-19PurchasePERCEPTIVE ADVISORS LLC10 percent owner
277,008
0.6854%
$5.36$1.48M+27.42%
2023-12-18PurchasePERCEPTIVE ADVISORS LLC10 percent owner
456,923
1.0714%
$5.41$2.47M+18.40%
2023-12-15PurchasePERCEPTIVE ADVISORS LLC10 percent owner
500,000
1.1857%
$5.97$2.98M+7.92%
2023-11-15SaleWhite TedPresident and CEO
11,558
0.0255%
$2.97$34,327+85.29%
2023-11-15SaleHayes Christopher G.Chief Legal Officer
11,558
0.0255%
$2.97$34,327+85.29%
2023-11-15SaleBonaccorso JoeChief Commercial Officer
11,266
0.0249%
$2.97$33,460+85.29%
2023-11-15SaleGoldenberg GaryChief Medical Officer
3,036
0.0067%
$2.97$9,017+85.29%
2023-11-15SaleKohler TerryChief Financial Officer
9,632
0.0213%
$2.97$28,607+85.29%
2023-11-14SaleWhite TedPresident and CEO
22,141
0.0523%
$2.93$64,873+102.57%
2023-11-14SaleHayes Christopher G.Chief Legal Officer
22,141
0.0523%
$2.93$64,873+102.57%
2023-11-14SaleBonaccorso JoeChief Commercial Officer
21,580
0.051%
$2.93$63,229+102.57%
2023-11-14SaleGoldenberg GaryChief Medical Officer
5,817
0.0137%
$2.93$17,044+102.57%
2023-11-14SaleKohler TerryChief Financial Officer
18,452
0.0436%
$2.93$54,064+102.57%
2023-07-24SaleWhite TedPresident and CEO
50,677
0.1113%
$4.83$244,770+3.13%

Insider Historical Profitability

13.24%
Manning Paul B
7851128
18.6645%
$7.05180+7.38%
PERCEPTIVE ADVISORS LLC10 percent owner
7099182
16.8769%
$7.05100<0.0001%
White TedPresident and CEO
170090
0.4044%
$7.0573+0.47%
Hayes Christopher G.Chief Legal Officer
123226
0.2929%
$7.0533+53.25%
Bonaccorso JoeChief Commercial Officer
92392
0.2196%
$7.0513<0.0001%
Goldenberg GaryChief Medical Officer
86257
0.2051%
$7.0513+61.6%
Kohler TerryChief Financial Officer
34416
0.0818%
$7.0502
EDELMAN JOSEPH
5038983
11.9792%
$7.0510+61.6%
Davidson Matt10 percent owner
2556179
6.0768%
$7.050160
Stalfort John A III
700205
1.6646%
$7.0540+51.41%
DAVIS A BRIANChief Financial Officer
12900
0.0307%
$7.0520+77.03%
Ballaron Craigdirector
10000
0.0238%
$7.0520+25.32%
Palczuk LindaChief Operating Officer
8500
0.0202%
$7.0530<0.0001%
Degnan ChrisChief Financial Officer
3000
0.0071%
$7.0510<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Perceptive Advisors$42.03M16.747.1M0%+$00.03
Avoro Capital Advisors Llc$23.68M9.434M0%+$00.28
Fidelity Investments$8.93M3.561.51M+0.01%+$1,101.12<0.01
The Vanguard Group$7.51M2.991.27M+0.6%+$45,045.28<0.0001
BlackRock$6.6M2.631.11M-1.91%-$128,363.38<0.0001
Geode Capital Management$2.66M1.06449,309+4.57%+$116,234.88<0.0001
State Street$2.44M0.97412,603+6%+$138,149.13<0.0001
Northern Trust$1.18M0.47198,722-0.08%-$941.28<0.0001
Deutsche Bank$1.09M0.43183,574+114.58%+$580,290.20<0.0001
Bml Capital Management Llc$1.07M0.42180,0000%+$00.81
SteelPeak Wealth$816,582.000.33137,936+0.44%+$3,552.000.04
Morgan Stanley$794,558.000.32134,216+20.58%+$135,633.00<0.0001
Miracle Mile Advisors$699,868.000.28118,2210%+$00.01
Wellington Management Company$606,119.000.24102,385New+$606,119.00<0.0001
Nuveen$562,589.000.2295,0320%+$0<0.0001
Bridgeway Capital Management$486,624.000.1982,200-23%-$145,336.000.01
Kornitzer Capital Management Inc Ks$439,566.000.1874,2510%+$00.01
Charles Schwab$327,708.000.1355,3560%+$0<0.0001
BNY Mellon$321,379.000.1354,287-2.59%-$8,536.64<0.0001
Kovitz$296,740.000.1250,1250%+$0<0.01
SPC Financial, Inc.$177,600.000.0730,0000%+$00.02
BECK MACK + OLIVER$177,600.000.0730,0000%+$0<0.01
Mml Investors Services Llc$162,000.000.0627,312-81.49%-$713,186.73<0.01
Bank of America$159,656.000.0626,969-26.48%-$57,494.87<0.0001
J. Goldman & Company$159,840.000.0627,000-75%-$479,520.000.01
Two Sigma$148,527.000.0625,089New+$148,527.00<0.0001
UBS$132,205.000.0522,332-8.05%-$11,573.56<0.0001
RhumbLine Advisers$130,688.000.0522,077-1.39%-$1,841.01<0.0001
Stifel$121,360.000.0520,5000%+$0<0.0001
Goldman Sachs$115,766.000.0519,555New+$115,766.00<0.0001
Creative Planning$112,587.000.0519,0180%+$0<0.0001
Mariner Llc$103,517.000.0417,486New+$103,517.00<0.0001
Barclays$86,000.000.0314,594-49.04%-$82,770.73<0.0001
Dimensional Fund Advisors$68,992.000.0311,6540%+$0<0.0001
Cambridge Investment Research Advisors Inc$68,000.000.0311,500New+$68,000.00<0.0001
BB&T$62,426.000.0310,5450%+$0<0.0001
American International Group$60,905.000.0210,288-0.86%-$526.88<0.0001
New York State Common Retirement Fund$58,000.000.029,769+7.56%+$4,078.82<0.0001
JPMorgan Chase$51,794.000.028,749-35.64%-$28,682.36<0.0001
Wells Fargo$45,809.000.027,738-21.86%-$12,816.81<0.0001
Spire Wealth Management$33,448.000.015,6500%+$0<0.01
Citigroup$22,525.000.013,805+27.68%+$4,883.87<0.0001
Salomon & Ludwin$17,168.000.012,9000%+$0<0.01
Legal & General$14,954.000.012,5260%+$0<0.0001
Royal Bank of Canada$15,000.000.012,481-71.69%-$37,974.61<0.0001
CalSTRS$12,426.000.012,099-38.91%-$7,914.99<0.0001
Simplex Trading Llc$13,000.000.012,289-49.39%-$12,687.64<0.0001
Ameritas Investment Partners Inc$10,206.00<0.011,7240%+$0<0.0001
Tower Research Capital$9,040.00<0.011,527-25.29%-$3,060.69<0.0001
Amalgamated Bank$4,000.00<0.01704-76.18%-$12,795.45<0.0001